Search result for "Solr search content"
Search Result for "%2A%3A%2A"
Clinical Trial
S2015 Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma (CTMS# 23-0072)
The primary objective of the trial is to assess whether there is no difference in disease-free survival for patients treated with a 1cm excision margin when compared to a 2cm margin for stage II primary melanomas (AJCC 8th edition; pT2b-pT4b).
provider
Sherri Cervantez, MD Palliative Medicine, Thoracic Oncology
provider
Ismail Jatoi, M.D. Surgical Oncology
provider
Anne–Marie Langevin, MD Pediatric Hematology/Oncology, Pediatrics
provider
Sukeshi Patel Arora, MD Gastrointestinal Oncology, Geriatric Oncology
provider
Chul Ha, MD Radiation Oncology, Hematology-Oncology
provider
Virginia Kaklamani, MD Breast Oncology, Hematology Oncology
provider